Investors and Media
ApaTech specializes in producing synthetic bone repair material. It has operations in London, England, Foxborough, MA, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 33 countries around the world.
The Company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the Company’s leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth.
ApaTech is backed by international investors, Encore Ventures and Healthcor and following its formation in 2001, the Company has raised more than $60m from investors.
ApaTech is committed to delivering shareholder value by:
- Using its scientific leadership to deliver targeted solutions to physicians, allowing them to significantly improve patient outcomes
- Responsibly managing the Company's financial resources
ApaTech has received several corporate business and research awards, including the Frost & Sullivan ‘2009 North American Biologics Company of the Year’ as a result of its success in the US orthobiologics market. More recently, ApaTech was awarded 3rd place in the UK Deloitte Technology Fast 50 (2009), to add to being recognized as Britain’s fastest growing medical technology company 3 years running 2009, 2008 and 2007 by the Sunday Times Fast Track 100 fastest growing private companies review.
For further Information:
ApaTech +44 20 8731 4640
Simon Cartmell, CEO
simon.cartmell@apatech.com
www.apatech.com
Waughton +44 20 7796 9999
Robin Hepburn
rhepburn@waughton.com
www.waughton.com
About Tech Track 100
The ninth annual Tech Track 100 league table was published in The Sunday Times on 27 September 2009, with main sponsors Barclays Commercial Banking, BDO Stoy Haywood and title sponsor Microsoft.
Tech Track 100 ranks Britain's fastest-growing private technology based companies based on sales growth as measured by compound annual growth rate over three financial years. www.fasttrack.co.uk